85 results
Page 2 of 5
8-K
EX-10.3
xx1wxabaavmxco6qfhpz
10 Jul 08
Departure of Directors or Principal Officers
12:00am
8-K
EX-10.1
624jai5
24 Mar 08
Acura Pharmaceuticals, Inc. Names
12:00am
424B3
3ocau7xl3ejtcasvac
20 Nov 07
Prospectus supplement
12:00am
CORRESP
2wfuk44
22 Oct 07
Correspondence with SEC
12:00am
8-K
EX-3.1
s0qemnlxk9yy d6
12 Oct 07
Amendments to Articles of Incorporation or Bylaws
12:00am
S-3
xgfjvc wd
1 Oct 07
Shelf registration
12:00am
8-K
EX-10.1
un7kli r654n0ycitj6
21 Aug 07
Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase Iii Clinical Trial for Lead Aversion® Technology Product Candidate
12:00am
8-K
EX-10.1
qiyr0yjw0dft9x9v
31 Jan 06
Acura Pharmaceuticals, Inc. Secures Bridge Funding
12:00am
8-K
EX-10.2
4o28m3jg6v3wo
10 Nov 05
Acura Pharmaceuticals, Inc. Reports Financial Results
12:00am
8-K
EX-10.1
i1prbni01dq0rxjc
16 Sep 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
i6zts11
23 Jun 05
Entry into a Material Definitive Agreement
12:00am